IPF, fibrotic hypersensitivity pneumonitis profiles differ

PHOENIX — When examining sphingolipid profiles in patients with idiopathic pulmonary fibrosis and patients with fibrotic hypersensitivity pneumonitis, different signatures emerged, according to data presented at the CHEST Annual Meeting.
“Distinguishing IPF from fibrotic hypersensitivity pneumonitis (fHP) is a challenge in both academic centers and community practice,” Jon Mullholand, MD, assistant professor at Virginia Commonwealth University, told Healio. “A major obstacle is that an inciting antigen often cannot be identified in patients with fHP, and the remaining clinical, imaging and

Few women act on knowledge of modifiable cancer risk factors

Most U.S. women are aware of modifiable risk factors for breast cancer but far fewer incorporate that understanding into everyday actions that could reduce their chances of developing the disease, according to survey results.
“There definitely is a gap between the level of knowledge and the level of action,” Alpa V. Patel, PhD, senior vice president of population science at American Cancer Society, told Healio.
One in eight women in the United States will develop breast cancer in their lifetime.
Family history, age, sex, race, ethnicity, breast tissue density and genetic factors all affect a